EGFR and neoplasm: In fact, AR signaling has been shown to interact with several oncogenic signaling pathways involved in promoting growth and resistance across various tumor types, such as PI3K/AKT/mTOR, EGFR, HER2/Neu, and Wingless-related integration site (65–69).